NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than 54,000 ...

Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s addictive ...

A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the ...

The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma boosted ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The attorneys general for eight holdout ...

The article discusses how U.S. bankruptcy courts are used to settle opioid liabilities, prioritizing public health and government payouts over individual victim compensation. Major cases like Purdue ...

The city is set to receive $48 million from a settlement with Purdue Pharma and its former owners, the Sackler family, for their role in producing and marketing highly addictive opioids. Mayor Eric ...

In the wake of the Supreme Court’s decision in Purdue Pharma that non-consensual third-party releases are impermissible under the Bankruptcy Code, bankruptcy courts across a multitude of jurisdictions ...

CHICAGO (WLS) -- ABC7's Tanja Babich takes a look at your top stories for Monday, Sept. 16. Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin has filed for ...